chest pain management - Nursing Case Study
Pathophysiology
• Primary mechanism: Myocardial ischemia occurs when there is a reduced blood flow to the heart muscle, often caused by coronary artery blockage, leading to chest pain as the heart tissue becomes oxygen-deprived, triggering nerve pathways that manifest as pain.
• Secondary mechanism: Gastroesophageal reflux disease (GERD) can cause chest pain through the backflow of stomach acid irritating the esophagus, where shared neural pathways with cardiac pain can confuse the nervous system, mimicking heart-related chest pain.
• Key complication: Untreated myocardial ischemia can progress to myocardial infarction (heart attack) as prolonged oxygen deprivation leads to irreversible heart muscle damage, emphasizing the need for prompt and accurate assessment in chest pain scenarios.
Patient Profile
Demographics:
56-year-old female, office manager
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Hyperlipidemia
• Current medications: Lisinopril, Metformin, Atorvastatin, Aspirin
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Chest pain
• Key symptoms: Persistent chest pain radiating to the left arm, shortness of breath, nausea, and lightheadedness
• Vital signs: Blood pressure 160/100 mmHg, heart rate 110 bpm, respiratory rate 22 breaths per minute, temperature 98.6°F, oxygen saturation 93% on room air
Section 1
As the initial assessment is conducted, the nurse notes that the patient’s chest pain has intensified and is now rated at 8 out of 10 on the pain scale. The pain is accompanied by increased shortness of breath, with the patient now visibly using accessory muscles to breathe. Auscultation of the lungs reveals bilateral crackles, suggesting potential pulmonary congestion. The patient's skin is diaphoretic and cool to the touch, which may indicate compromised cardiac output. Upon further questioning, the patient reports that the pain has been persistent for over an hour and has not been alleviated by rest or her previously taken aspirin. This prompts an immediate re-evaluation of the patient's status and the need for urgent diagnostic testing to rule out acute myocardial infarction.
The healthcare team quickly proceeds with an electrocardiogram (ECG), which reveals ST-segment elevation in the anterior leads, consistent with an ST-elevation myocardial infarction (STEMI). Blood tests indicate elevated cardiac biomarkers, with a troponin level significantly higher than the normal range, further supporting the diagnosis of myocardial infarction. These findings suggest that myocardial ischemia has progressed, and there is significant heart muscle injury. The patient's blood pressure remains elevated at 150/95 mmHg, and her heart rate is now 120 bpm, indicating a sympathetic response to the ongoing cardiac event.
Given these developments, the focus shifts to immediate intervention to restore coronary blood flow and minimize heart damage. The patient is prepared for urgent transfer to the cardiac catheterization lab for percutaneous coronary intervention (PCI). As the team begins administering oxygen and initiates dual antiplatelet therapy, the nurse continues to monitor for signs of further complications, such as arrhythmias or hemodynamic instability, which could arise from the evolving cardiac event. The patient's journey now hinges on the success of rapid intervention and the careful management of potential complications that can occur in the acute phase of myocardial infarction.
Section 2
As the medical team proceeds with the urgent intervention, the patient is closely monitored for any new complications. During the preparation for the cardiac catheterization, the nurse observes a sudden change in the patient's condition. The patient begins to exhibit signs of acute distress, including increased anxiety, restlessness, and a new onset of palpitations. The cardiac monitor reveals the development of ventricular tachycardia, a potential complication of myocardial infarction that could lead to hemodynamic instability. The patient's blood pressure has dropped to 90/60 mmHg, and her heart rate has escalated to 160 bpm, indicating a significant deterioration in cardiac output.
In response to these alarming changes, the healthcare team quickly implements advanced cardiac life support protocols. Intravenous antiarrhythmic medication, such as amiodarone, is administered to stabilize the heart rhythm. The patient is repositioned to optimize cardiac output and oxygen delivery. The nurse meticulously reassesses the patient's vital signs and performs a focused cardiovascular examination to identify any additional signs of cardiac compromise. The patient remains diaphoretic and pale, with diminished capillary refill, emphasizing the need for prompt correction of the arrhythmia and support of circulatory function.
As the antiarrhythmic intervention begins to take effect, the patient's heart rate gradually decreases, and her blood pressure stabilizes at 110/70 mmHg. The ventricular tachycardia resolves, and the patient reports feeling slightly more comfortable, though still experiencing chest discomfort. This response to intervention underscores the importance of continuous monitoring and rapid action in managing acute complications during a myocardial infarction. However, the episode serves as a reminder of the potential for rapid changes in the patient's status, necessitating vigilant observation and readiness to adapt the treatment plan. With the arrhythmia managed, the team proceeds with the planned transfer to the cardiac catheterization lab, where the next steps in the patient's care will focus on definitive coronary revascularization.
Section 3
As the patient is transferred to the cardiac catheterization lab, the medical team remains alert for any new complications that might arise. Upon arrival, the interventional cardiologist swiftly reviews the patient's recent clinical findings and notes the critical need for further diagnostic clarity. The cardiac catheterization reveals significant stenosis in the left anterior descending artery, confirming the suspicion of an acute coronary syndrome as the underlying cause of the myocardial infarction. The team decides to proceed with percutaneous coronary intervention (PCI) to restore adequate blood flow to the compromised myocardial tissue.
During the procedure, the nurse closely monitors the patient's hemodynamic parameters and observes a slight increase in chest pain, suggesting ongoing ischemia. Concurrently, the patient's oxygen saturation dips to 92%, prompting the administration of supplemental oxygen. The interventional team expertly navigates the coronary vasculature, successfully deploying a drug-eluting stent to address the critical blockage. As the stent expands, the patient reports a gradual easing of chest pain, and her oxygen saturation improves to 96%, indicating successful revascularization.
Post-procedure, the patient is transferred to the coronary care unit for continuous monitoring. Her vital signs stabilize with a blood pressure of 115/75 mmHg and a heart rate of 80 bpm. The nurse conducts a thorough assessment, noting improved skin color and capillary refill time, reflecting enhanced perfusion. Despite the positive outcome, the team remains cautious, aware of the potential for post-procedural complications such as stent thrombosis or bleeding. The patient is placed on dual antiplatelet therapy to mitigate these risks, and the healthcare team prepares to educate her on lifestyle modifications and medication adherence to prevent future cardiac events.
Section 4
As the patient settles into the coronary care unit, the nurse continues diligent monitoring, particularly vigilant for signs of new complications. Approximately two hours post-PCI, the patient begins to exhibit mild shortness of breath and a feeling of heaviness in her chest, which she rates as a 3 out of 10 on the pain scale. The nurse notes a slight increase in the patient's heart rate to 92 bpm and a decrease in blood pressure to 105/70 mmHg. Recognizing these changes, the nurse conducts a thorough assessment, checking for signs of heart failure or potential stent complications such as thrombosis.
Laboratory results return, showing a slight elevation in cardiac biomarkers, which is expected post-procedure, but also a concerning drop in hemoglobin levels to 10.2 g/dL from an initial 12.5 g/dL. This prompts the healthcare team to consider the possibility of a bleeding complication, likely related to the dual antiplatelet therapy. An immediate review of the patient's coagulation profile reveals prolonged clotting times, indicating increased bleeding risk. The team decides to adjust her medication regimen, carefully balancing the need to prevent stent thrombosis with the risk of bleeding.
In response to these findings, the medical team orders a chest X-ray to rule out pulmonary complications and an echocardiogram to assess cardiac function. The nurse informs the patient and her family about the need for additional tests and continuous monitoring, reassuring them that these measures are precautionary and integral to her recovery process. As the healthcare team awaits the imaging results, they remain poised to intervene promptly should the patient's condition change, demonstrating the importance of vigilant post-procedural care in preventing and managing complications.
Section 5
As the nurse continues to closely monitor the patient, the chest X-ray and echocardiogram results arrive, revealing new diagnostic insights. The chest X-ray indicates mild pulmonary congestion, suggestive of early heart failure, likely exacerbated by the fluid shifts post-procedure and the slight decrease in cardiac output. The echocardiogram shows a reduced ejection fraction of 45%, down from the patient's baseline of 55%, supporting the suspicion of compromised cardiac function. These findings prompt the healthcare team to initiate a low-dose diuretic therapy to alleviate the pulmonary congestion while maintaining careful fluid balance to avoid exacerbating potential bleeding.
Meanwhile, the patient's vital signs show subtle yet concerning changes. Her heart rate has increased further to 98 bpm, and her blood pressure remains on the lower side at 102/68 mmHg. The nurse notes slight jugular venous distension and crackles at the lung bases during auscultation, reinforcing the need for vigilant monitoring and prompt intervention. These clinical indicators suggest the patient is teetering on the edge of decompensated heart failure, necessitating frequent reassessment of her respiratory status and hemodynamics.
In response to these developments, the healthcare team adjusts the patient's medication regimen, carefully titrating the diuretic dose while considering the continuation of antiplatelet therapy to prevent stent thrombosis. This delicate balance calls for astute clinical reasoning, as the team must weigh the risks of exacerbating bleeding against the dangers of thrombotic events. The nurse educates the patient and her family about the current management strategy, emphasizing the importance of symptom reporting, such as increased shortness of breath or chest discomfort, ensuring they remain active participants in the patient's ongoing care. As the team continues to monitor the patient's response to interventions, they remain vigilant for any signs of further complications, ready to adapt their approach as necessary to support her recovery.